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Introduction: Inflammation plays a major role in the multifactorial process of trauma associated coagulopathy. The
vagus nerve regulates the cholinergic anti-inflammatory pathway. We hypothesized that efferent vagus nerve
stimulation (VNS) can improve coagulopathy by modulating the inflammatory response to hemorrhage.
Methods: Wistar rats (n = 24) were divided in 3 groups: Group (G1) Sham hemorrhagic shock (HS); (G2) HS w/o
VNS; (G3) HS followed by division of the vagus nerves and VNS of the distal stumps. Hemorrhage (45% of baseline
MAPx15 minutes) was followed by normotensive resuscitation with LR. Vagus nerves were stimulated (3.5 mA, 5 Hz)
for 30 sec 7 times. Samples were obtained at baseline and at 60 minutes for thromboelastometry (Rotem®) and
cytokine assays (IL-1 and IL-10). ANOVA was used for statistical analysis; significance was set at p < 0.05.
Results: Maximum clot firmness (MCF) significantly decreased in G2 after HS (71.5 ± 1.5 vs. 64 ± 1.6) (p < 0.05). MCF
significantly increased in G3 compared to baseline (67.3 ± 2.7 vs. 71.5 ± 1.2) (p < 0.05). G3 also showed significant
improvement in Alfa angle, and Clot Formation Time (CFT) compared to baseline. IL-1 increased significantly in
group 2 and decrease in group 3, while IL-10 increased in group 3 (p < 0.05).
Conclusions: Electrical stimulation of efferent vagus nerves, during resuscitation (G3), decreases inflammatory
response to hemorrhage and improves coagulation.
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Coagulopathy is linked to approximately 50% of the trauma
associated deaths that occur within the first 48 hours after
injury [1-3]. That condition is present in more than 25% of
severely injured patients on admission, and is associated
with a fourfold increased risk of death [1,4]. Severe trauma
and hemorrhagic shock trigger major systemic inflam-
matory response. An exacerbated response leads to a
pathophysiologic process that ultimately results in multiple
organ failure [5-7]. There is a large body of evidence to
support the correlation between excessive inflamma-
tion and coagulation dysfunction [7-12]. Therefore,* Correspondence: rezendenetoj@smh.ca
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article, unless otherwise stated.inflammation is considered a key initiator of trauma
associated coagulopathy [10,13,14].
The central nervous system modulates inflammatory
response through hormonal and neuronal pathways. The
vagus nerve has an important role in this process. Previ-
ous research demonstrated that electrical stimulation
of the efferent vagus nerve inhibits pro-inflammatory
cytokines through the “cholinergic anti-inflammatory
pathway” [7,15-17]. Even though, previous studies have
shown that vagus nerve stimulation protects against
excessive inflammatory response in hemorrhagic shock,
the effect on coagulation has been scarcely investigated
[18]. Thus, the present study sought to investigate the
acute hemostatic effect of VNS on coagulation and cyto-
kine production in a controlled hemorrhagic shock model.
The study was approved by the Animal ResearchCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Methods
Male Wistar rats (200-250 g) were acclimated for
2 weeks, individually housed, and maintained at 25°C
on 12-hour light/day cycles. Animals were fed rat chow
(Ratochow-Purina; Caxias, Brazil), and water ad libitum.
Experimental groups
Twenty-four (n = 24) animals were randomly divided in
3 groups (n = 8 per group) according to resuscitation
regimen:
– Group 1 (Sham): Animals underwent surgical
procedures but no hemorrhage.
– Group 2: Hemorrhage and resuscitation with
lactated Ringer’s (LR) but no vagus nerve
stimulation (VNS).
– Group 3: Hemorrhage followed by bilateral division
of the vagus nerves and VNS of the distal stumps
(efferent) during resuscitation.
Pre-hemorrhage procedures and dissection of the vagus
nerves
Animals were anesthetized with ketamine 60 mg/kg and
xylazine 15 mg/kg (Fort Dodge Animal Health, Fort Dodge,
IA) administered by intraperitoneal injection. Additional
intravenous doses were given if needed. The right internal
jugular vein and the right carotid artery were cannulated
with 21G peripheral intravenous catheters previously filled
with LR (Johnson & Johnson, Sao Jose dos Campos, Brazil).
The vagus nerves were carefully dissected and tagged with
a loop of 3–0 silk suture (Polysuture®, Sao Sebastiao do
Paraiso, Minas Gerais, Brazil). Mean arterial pressure
(MAP) was monitored continuously on the right carotid
artery (Pro-Paq Protocol Systems, Beaverton, OR). A blood
sample (1 ml) was obtained from the right carotid artery
for baseline thromboelastometry (ROTEM® Coagulation
Analyzer, Pentapharm, Munich, Germany). The sample was
immediately transferred to a tube containing 3.2% sodium
citrate as anticoagulant (MiniCollect®, Vacuette, Monroe,
NC). Thromboelastometry was performed on temperature-
corrected blood samples using NATEM® (Non-Activated
TEM) and Star-tem® reagent to recalcify citrated blood
(Ref. Number 503–01). Thromboelastometry parameters
were calculated with the coagulation dynamics evaluation
software (DyCoDerivAn; Avordusol, Rissov, Denmark). The
following parameters were assessed: clotting time (CT),
clot formation time (CFT), alpha angle (α), maximum clot
firmness (MCF); at baseline and at the end of the experi-
ment. A different blood sample was placed in a centrifuge
tube (Eppendorf do Brasil Ltda, Sao Paulo, Brazil) with
ethylenediaminetetra-acetic acid as anticoagulant forcytokine assay (IL-1β and IL-10). In brief, plasma was
separated by centrifugation at 1600 × g for 15 minutes
at 4°C. Samples were analyzed at a 1:5 dilution in potas-
sium phosphate buffer. Enzyme-linked immunobsorbent
assay plates (ELISA) (Neogen® Corporation, Indaiatuba,
Brazil) were coated with sheep anti-rat IL-1β and IL-10
polyclonal antibodies (1–2 μg/ml) overnight. The plates
were washed and blocked with 1% bovine serum albumin,
and incubated overnight with samples of recombinant rat
cytokine. Biotinylated polyclonal antibodies were used at a
1:1000 to 1:2000 dilution. The plates were washed and in-
cubated with avidin-horseradish peroxidase (Dako North
America Ltd., Carpinteria, CA) for 15 minutes. After a
subsequent wash they were incubated with o-phenylenedi-
amine and H2O2 for another 15 minutes. The reaction
was stopped with sulfuric acid (150 μl/1.0 M); optical
densities at 490 nm were determined. Cytokine assays
were performed using blood samples obtained at baseline
and at the end of the experiment.
Hemorrhage/resuscitation procedures and vagus nerve
stimulation
Total blood volume was calculated as (TBV = 0.06 ×
Weight (g) + 0.77). Forty percent of the estimated TBV
was taken from the right carotid artery. Thereafter,
MAP was maintained at 45% of baseline level (MAP ×
0.45) for 15 minutes (Figure 1). No fluids or blood prod-
ucts were given during this period to simulate Emergency
Medical Services (EMS) arrival time. Resuscitation began
with a bolus of LR (20 ml/Kg) infused over 3 minutes
through the right internal jugular vein. Additional vol-
umes of LR were infused to maintain MAP at baseline ±
5 mmHg. The resuscitation phase lasted for 45 minutes.
Vagus nerves of group 3 animals were divided bilaterally.
Subsequently, a total of seven stimuli were applied to the
distal stump of the nerve bilaterally, during resuscitation,
using a Grass Nerve Stimulator (Grass Technologies -
Warwick, RI). Stimuli were 3.5 mA/5Hz and lasted for
30 seconds. A five minute interval was allowed between
each stimulation (total time 35 minutes). Animals were
euthanized with an anesthetic overdose after the final
blood sample was obtained (Figure 1).
Statistical analysis
One-way analysis of variance (ANOVA) was performed
with post hoc analysis using Tukey’s test for multiple
comparison between experimental means; data are reported
as mean ± SEM, p < 0.05 was considered statistically
significant.
Results
Hemodynamic response and cytokine levels
Average MAP was 91.1 ± 1.8 mmHg at baseline among
the groups (p > 0.05). Bleeding provoked a significant
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Figure 1 Timeline of events and procedures during the experiment. Hemorrhage was induced by withdrawal of 40% of total blood volume
(TBV) and maintenance of mean arterial blood pressure (MAP) at 45% of baseline. LR = lactated Ringers.
Rezende-Neto et al. Journal of Trauma Management & Outcomes 2014, 8:15 Page 3 of 6
http://www.traumamanagement.org/content/8/1/15decrease in MAP in groups 2 and 3 compared to sham
(G1), and this difference persisted throughout the first
20 minutes of the experiment; respectively 62.3 ± 3.7 mmHg
vs. 85.5 ± 3.5 mmHg (p < 0.05). Mean arterial pressure
response to bleeding and resuscitation was unaffected by
VNS (group 3) compared to group 2; p > 0.05 (Figure 2).
There was no significant difference in the volumes of lac-
tated Ringer’s used during resuscitation between groups 2
and 3, respectively 4.8 ± 0.3 ml and 4.6 ± 0.2 ml (p > 0.05).
Results showed that group 2 animals had a significant
increase in plasma IL-1 after hemorrhage/resuscitation
compared to baseline and final sham; respectively 8.5 ±
4.3 pg/ml vs. 22.6 ± 10.5 pg/ml, and 4.5 ± 1.3 vs. 22.6 ±
10.5 pg/ml (p < 0.05). In contrast, IL-1 levels decreased
significantly when VNS was performed during resusci-
tation (group 3) compared to baseline and final group


































Figure 2 Mean arterial blood pressure during hemorrhage and resusc
(no vagus nerve stimulation) and 3. Group 3 animals also underwent vagus n
(8 animals per group). *p < 0.05 vs. baseline and sham; one way analysis of va0.7 ± 0.5 pg/ml (p < 0.05). As expected, sham hemorrhage
did not alter IL-1 levels significantly (Figure 3). Group 3
animals were also assessed for anti-inflammatory cytokine
IL-10. There was a significant increase in plasma IL-10
levels with VNS during hemorrhage resuscitation com-
pared to baseline; respectively 26.3 ± 3.5 pg/ml vs. 40.2 ±
6.0 pg/ml (p < 0.05).
Thromboelastometric parameters
Hemorrhage and resuscitation without VNS (group 2)
resulted in a significant decrease in MCF compared to
baseline; respectively 71.5 ± 1.8 mm vs. 64.0 ± 1.7 mm
(p < 0.05). In contrast, when VNS was performed during
resuscitation (group 3) MCF increased significantly
compared to baseline 67.3 ± 2.7 mm vs. 74.5 ± 1.5 mm
(p < 0.05) (Figure 4-A). Vagus nerve stimulation during
resuscitation also improved other tromboelastometricponse




itation. Lactated Ringer’s infusion began at 15 minutes in groups 2
erve stimulation starting at the 15th minute. Data represent mean ± SEM


































Figure 3 Interleukin 1β plasma levels. Samples obtained at baseline and after resuscitation. Data represent mean ± SEM (8 animals per group).
*p < 0.05 vs. baseline group 2 (resuscitation without vagus nerve stimulation), final group 1 (sham), and final group 3 (resuscitation with vagus
nerve stimulation); one way analysis of variance (ANOVA). VNS = Vagus nerve stimulation.
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cantly 72.7 ± 2.5o vs. 78.7 ± 1.5° (p < 0.05), while the CFT
decreased 90.3 ± 16.2 vs. 59.7 ± 8.9 seconds (p < 0.05);
compared to baseline. Hemorrhage followed by resuscita-
tion without VNS (group 2) did not improve those param-























































Figure 4 Rotational thromboelastometry. Samples obtained at baseline
group). A, *p < 0.05 vs. baseline group 2 (resuscitation without vagus nerve
B, *p < 0.05 vs. baseline group 3. C, *p < 0.05 vs. baseline group 3. VNS = VDiscussion
Our results indicate that efferent VNS, during hemorrhagic
shock resuscitation, improves hemostasis by decreasing
inflammatory response. Immunomodulatory effects
of efferent VNS result from the interaction between
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*
and after resuscitation. Data represent mean ± SEM (8 animals per
stimulation); **p < 0.05 vs. baseline group 3 (vagus nerve stimulation).
agus nerve stimulation.
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anti-inflammatory pathway” [15,16]. Stimulation of this
receptor’s subunit also inhibits the activation of nuclear
factor (NF-κB), high mobility group B1 (HMGB1), IL-1β,
TNFα, and other pro-inflammatory cytokines [15-17,19].
Immunomodulation induced by VNS was previously
described in a wide range of experimental models par-
ticularly those involving septic challenges [15,20-22].
Cytokines play a major role in the systemic inflammatory
response unleashed by severe trauma, and this condition
promotes abnormal hemostasis [23-25]. Inflammatory
dysfunction of endothelial cells is an important event
in this process. Accordingly, previous research showed
that shedding of syndecan-1, a proteoglycan component
of endothelial cell glycocalyx, facilitates resolution of
inflammation and clearance of chemokines [26]. In keep-
ing with that hypothesis, data from hemorrhagic shock
trauma patients showed that interferon-γ, fractalkine, and
IL1-β correlated negatively with syndecan-1 shedding,
whereas IL-10 had a positive correlation [27]. Interest-
ingly, our findings showed an increase in plasma IL-10
levels and reduction in IL-1β in response to VNS. Because
inflammation can produce both inhibition and exacerba-
tion of the clotting process it is conceivable to hypothesize
that VNS produced a more balanced hemostatic response
that ultimately resulted in improved coagulation; evi-
denced in the present study by improved clot formation
kinetics and enhanced clot firmness. Moreover, previous
research showed that IL-10 not only decreases NF-κB
activation, expression of intracellular adhesion mol-
ecule 1 (ICAM-1), and vascular cell adhesion molecule
1 (VCAM-1), but also inhibits pro-inflammatory cyto-
kine production in a feedback loop [28,29]. Thereby
protecting endothelial cells from injury provoked by
excessive inflammatory response. Accordingly, higher
levels of IL-10 and decreased levels of IL-1β, after VNS
in our model, could have decreased hemorrhage induced
endothelial dysfunction and also contributed to better
hemostasis.
Our findings provide additional information compared
to a recent study wherein the hemostatic effect of VNS
was investigated by means of a peripheral hemorrhage
animal model [18]. In our study, hemorrhage was more
severe and resulted in significant hypotension setting the
stage for major inflammatory response. Thus, we be-
lieve that this model was more suitable to investigate
the immunomodulatory effect of VNS on hemostasis.
Our results also corroborate previous research that
showed no cardiovascular dysfunction as a result of effer-
ent VNS [30-33]. Evidenced by similar hemodynamic re-
sponse and fluid requirements, despite severe hemorrhage
and regardless of VNS. Several different strategies of VNS
are reported in the literature [15,16,18,20-22,34]. Using the
same hemorrhage model described herein, we performedpilot experiments to determine what would be the best
method for this study. Interestingly, we found no difference
in the coagulation profile or in cytokine levels when vagus
nerves were stimulated but not divided (data not shown).
Likewise, bilateral vagotomy only or stimulation of the
proximal stumps after vagotomy did not result in signifi-
cant improvement in coagulation or change in cytokine
levels compared to non-stimulated vagus (data not shown).
This study has several limitations. Inter-species com-
parison showed that rats are particularly hypercoagulable
[35]. This could potentially have augmented the pro-
coagulant effect provoked by VNS. Furthermore, we did
assess for fibrinolysis, which was recently described as
an independent predictor of mortality in trauma patients
[36,37]. Even though significant hypotension was pro-
duced in the animals, we did not simulate major tissue
injury or assess the degree of hypoperfusion. Moreover,
blood products were not used during resuscitation
restricting the clinical relevance of the model.
Conclusions
This study demonstrated that efferent VNS during
hemorrhagic resuscitation improves coagulation. Even
though the precise mechanism was not investigated,
activation of the cholinergic anti-inflammatory pathway
was involved in that response.
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